HouseMarketBook

20 Penlan Crescent, Swansea

Terraced house · Freehold · SA2 0RL

Sold for, February 2021£300,000No floor area on record

Sold for £300,000 in February 2021.

Indexed with the UK House Price Index for Swansea, that sale is worth about £392,700 today. The 101 terraced houses counted in SA2 0 over the last 24 months sold for a median of £2,060 per square metre. No energy certificate matches this address, so there is no floor area and no price per square metre; its sold prices are shown in full.

Today's value£392,700
SA2 0 median, terraced house£2,060per m²

Sale history

HM Land Registry · 3 sales since 1995
DatePrice paid£ / m²Growth / yrAfter inflationToday's value
Feb 2021£300,000—+3.4%+1.4%£392,700
Aug 2007£190,000———£292,200
Oct 2006£185,000———£304,500

Growth is the compound annual rate between one sale and the next, shown when they are at least a year apart; after inflation uses CPIH for the same months. Today's value indexes each sale forward with the UK House Price Index for Swansea to September 2026.

Recent sales in SA2 0

Newest first
AddressDatePriceSize£ / m²
17 Vivian RoadSep 2026£183,50083 m²£2,210
95 Rhyddings TerraceSep 2026£197,50099 m²£1,990
36 Edgeware RoadAug 2026£200,00079 m²£2,530
6 Canterbury RoadAug 2026£210,000103 m²£2,040
23 Cambridge StreetAug 2026£217,50070 m²£3,110
141 Cockett RoadAug 2026£122,50087 m²£1,410
71 Penlan CrescentAug 2026£310,00092 m²£3,370
10 Hazelmere RoadAug 2026£382,000137 m²£2,790
14 Pinewood RoadAug 2026£205,000100 m²£2,050
3 Lon CadogAug 2026£252,00093 m²£2,710
Everything in SA2 0

About this page

What did 20 Penlan Crescent sell for? 20 Penlan Crescent last sold for £300,000 in February 2021. HM Land Registry records 3 sales since 2006. Price per square metre is the price paid divided by that area; today's value indexes the latest sale forward with the UK House Price Index. None of these figures is a valuation.

Sales to September 2026 · HM Land Registry price paid data · MHCLG energy certificates · UK House Price Index to September 2026 · An index-based comparison of sold prices, not a valuation.